載入...
Antihypertensive Efficacy of Olmesartan Medoxomil, a New Angiotensin II Receptor Antagonist, as Assessed by Ambulatory Blood Pressure Measurements
Olmesartan medoxomil is a new angiotensin II receptor blocker. In this randomized, double‐blind, placebo‐controlled study, the efficacy and safety of olmesartan medoxomil was assessed in 334 patients with moderate to severe essential hypertension. Patients were randomized to receive placebo; 5, 20,...
Na minha lista:
| 發表在: | J Clin Hypertens (Greenwich) |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Le Jacq Communications, Inc.
2007
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8101835/ https://ncbi.nlm.nih.gov/pubmed/12368570 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1524-6175.2002.01051.x |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|